Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Drug Targeting|June 17, 2006
EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cellsChristoph Mamot, Reto Ritschard, Willy Küng, et al.
Journal of Bacteriology|June 28, 2011
Genome analysis of a Mycoplasma hyorhinis strain derived from a primary human melanoma cell lineJonathan D Kornspan, Inna Lysnyansky, Tamar Kahan, et al.
Journal of Drug Targeting|April 24, 2012
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cellsChristoph Mamot, Reto Ritschard, Andreas Wicki, et al.
Diagnostic Microbiology and Infectious Disease|April 17, 2012
Optimized serodiagnosis of Mycoplasma pneumoniae infectionsRoger Dumke, Andreas Strubel, Camille Cyncynatus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2009
Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugsManuel Haschke, Tanja Vitins, Saskia Lüde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trialViviane Hess, Marc Salzberg, Markus Borner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II studyRalph Winterhalder, Simone Deschler-Marini, Christine Landmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growthAndreas Wicki, Christoph Rochlitz, Annette Orleth, et al.
International Journal of Hematology|December 21, 2011
Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 studyRichard Herrmann, Marian Sturm, Kathryn Shaw, et al.
Oncology Research and Treatment|May 24, 2014
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort studyAndreas Wicki, Frank Hermann, Vincent Prêtre, et al.
Pageof 9